Follow
Tim Van den Wyngaert
Tim Van den Wyngaert
Professor of Nuclear Medicine, University of Antwerp
Verified email at uantwerp.be - Homepage
Title
Cited by
Cited by
Year
The EANM practice guidelines for bone scintigraphy
T Van den Wyngaert, K Strobel, WU Kampen, T Kuwert, ...
European journal of nuclear medicine and molecular imaging 43, 1723-1738, 2016
3812016
Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment
O Nicolatou-Galitis, M Schiødt, RA Mendes, C Ripamonti, S Hope, ...
Oral surgery, oral medicine, oral pathology and oral radiology 127 (2), 117-135, 2019
3342019
Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases
S Otto, C Pautke, T Van den Wyngaert, D Niepel, M Schiødt
Cancer treatment reviews 69, 177-187, 2018
2902018
Bisphosphonates and osteonecrosis of the jaw: cause and effect or a post hoc fallacy?
T Van den Wyngaert, MT Huizing, JB Vermorken
Annals of Oncology 17 (8), 1197-1204, 2006
1892006
Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome
T Van den Wyngaert, T Claeys, MT Huizing, JB Vermorken, E Fossion
Annals of Oncology 20 (2), 331-336, 2009
1732009
Maintenance fluid therapy and fluid creep impose more significant fluid, sodium, and chloride burdens than resuscitation fluids in critically ill patients: a retrospective …
N Van Regenmortel, W Verbrugghe, E Roelant, T Van den Wyngaert, ...
Intensive care medicine 44, 409-417, 2018
1572018
18F-NaF PET/CT: EANM procedure guidelines for bone imaging
M Beheshti, FM Mottaghy, F Payche, FFF Behrendt, T Van den Wyngaert, ...
European journal of nuclear medicine and molecular imaging 42, 1767-1777, 2015
1342015
Osteonecrosis of the jaw related to the use of bisphosphonates
T Van den Wyngaert, MT Huizing, JB Vermorken
Current opinion in oncology 19 (4), 315-322, 2007
1162007
RapidArc, SmartArc and TomoHD compared with classical step and shoot and sliding window intensity modulated radiotherapy in an oropharyngeal cancer treatment plan comparison
D Van Gestel, C van Vliet-Vroegindeweij, F Van den Heuvel, W Crijns, ...
Radiation Oncology 8, 1-12, 2013
922013
FDG-PET/CT for treatment response assessment in head and neck squamous cell carcinoma: a systematic review and meta-analysis of diagnostic performance
N Helsen, T Van den Wyngaert, L Carp, S Stroobants
European journal of nuclear medicine and molecular imaging 45, 1063-1071, 2018
722018
RANK ligand inhibition in bone metastatic cancer and risk of osteonecrosis of the jaw (ONJ): non bis in idem?
T Van den Wyngaert, K Wouters, MT Huizing, JB Vermorken
Supportive Care in Cancer 19, 2035-2040, 2011
722011
Molecular imaging of apoptosis: the case of caspase-3 radiotracers
L Beroske, T Van den Wyngaert, S Stroobants, P Van der Veken, F Elvas
International Journal of Molecular Sciences 22 (8), 3948, 2021
632021
Effect of isotonic versus hypotonic maintenance fluid therapy on urine output, fluid balance, and electrolyte homeostasis: a crossover study in fasting adult volunteers
N Van Regenmortel, T De Weerdt, AH Van Craenenbroeck, E Roelant, ...
BJA: British Journal of Anaesthesia 118 (6), 892-900, 2017
632017
SPECT/CT: standing on the shoulders of giants, it is time to reach for the sky!
T Van den Wyngaert, F Elvas, S De Schepper, JA Kennedy, O Israel
Journal of Nuclear Medicine 61 (9), 1284-1291, 2020
582020
Fluorodeoxyglucose-positron emission tomography/computed tomography after concurrent chemoradiotherapy in locally advanced head-and-neck squamous cell cancer: the ECLYPS study
T Van den Wyngaert, N Helsen, L Carp, S Hakim, MJ Martens, I Hutsebaut, ...
Journal of Clinical Oncology 35 (30), 3458-3464, 2017
582017
Impact of chloride and strong ion difference on ICU and hospital mortality in a mixed intensive care population
N Van Regenmortel, W Verbrugghe, T Van den Wyngaert, PG Jorens
Annals of Intensive Care 6, 1-9, 2016
572016
Bisphosphonates in oncology: rising stars or fallen heroes
T Van den Wyngaert, MT Huizing, E Fossion, JB Vermorken
The oncologist 14 (2), 181-191, 2009
502009
Neoadjuvant systemic therapy in breast cancer: Challenges and uncertainties
M Van de Wiel, Y Dockx, T Van den Wyngaert, S Stroobants, WAA Tjalma, ...
European Journal of Obstetrics & Gynecology and Reproductive Biology 210 …, 2017
472017
SPECT/CT in postoperative painful hip arthroplasty
T Van den Wyngaert, F Paycha, K Strobel, WU Kampen, T Kuwert, ...
Seminars in nuclear medicine 48 (5), 425-438, 2018
462018
154 compared to 54 mmol per liter of sodium in intravenous maintenance fluid therapy for adult patients undergoing major thoracic surgery (TOPMAST): a single-center randomized …
N Van Regenmortel, S Hendrickx, E Roelant, I Baar, K Dams, ...
Intensive Care Medicine 45, 1422-1432, 2019
442019
The system can't perform the operation now. Try again later.
Articles 1–20